Oral administration of Akkermansia muciniphila elevates systemic antiaging and anticancer metabolites

Claudia Grajeda‐Iglesias(Inserm), Sylvère Durand(Inserm), Romain Daillère(Laboratoire d'études sur les monothéismes), Kristina Iribarren(Inserm), Fabien Lemaître(Inserm), Lisa Derosa(Inserm), Fanny Aprahamian(Inserm), Noélie Bossut(Inserm), Nitharsshini Nirmalathasan(Inserm), Frank Madeo(University of Graz), Laurence Zitvogel(Inserm), Guido Kroemer(Inserm)
Aging
March 2, 2021
Cited by 152Open Access
Full Text

Abstract

(Akk) in the human gut is associated with good health, leanness and fitness. Mouse experimentation has demonstrated positive effects for Akk, which counteracts aging, mediates antiobesity and antidiabetic effects, dampens inflammation and improves anticancer immunosurveillance. Clinical trials have confirmed antidiabetic effects for Akk. Here, we investigated the time-dependent effects of oral administration of Akk (which was live or pasteurized) and other bacteria to mice on the metabolome of the ileum, colon, liver and blood plasma. Metabolomics was performed by a combination of chromatographic and mass spectrometric methods, yielding a total of 1.637.227 measurements. Akk had major effects on metabolism, causing an increase in spermidine and other polyamines in the gut and in the liver. Pasteurized Akk (Akk-past) was more efficient than live Akk in elevating the intestinal concentrations of polyamines, short-chain fatty acids, 2-hydroxybutyrate, as well multiple bile acids, which also increased in the circulation. All these metabolites have previously been associated with human health, providing a biochemical basis for the beneficial effects of Akk.


Related Papers

No related papers found

Powered by citation graph analysis